Workflow
中毅达再度提示风险 两个多月股价涨幅近300%

Core Viewpoint - Zhongyida's stock price has increased by 298.76% since March 10, 2025, despite the company reporting a net loss of 14.08 million yuan for the fiscal year 2024 [1]. Financial Performance - The company reported a net profit of 13.76 million yuan in the first quarter of 2025 [1]. - As of the end of the first quarter of 2025, the company's goodwill was valued at 160 million yuan, while its net asset value was 81.01 million yuan, indicating that the goodwill exceeds the net asset value [2]. - The cumulative undistributed profit balance as of December 31, 2024, was -2.098 billion yuan, which means profits will first be used to cover previous losses before any cash dividends can be distributed [2]. Market Position - Zhongyida's price-to-book ratio is 193.21, significantly higher than the industry average of 1.92 for the chemical raw materials and chemical products manufacturing sector [1]. - The company acknowledges that its stock price is significantly detached from its fundamentals, indicating a potential for market over-exuberance and high speculation risk [1]. Business Operations - The main operating entity of Zhongyida is its wholly-owned subsidiary, Chifeng Ruiyang, which focuses on the production and sales of fine chemical products, including various types of pentaerythritol and feed products [1]. - The company has not reported any significant changes in its fundamental operations and has confirmed that its production activities are normal [2][3]. Goodwill and Risks - In 2023, Zhongyida recorded a goodwill impairment loss of 49.99 million yuan, but no impairment loss was reported for 2024 [2]. - There is a risk of further goodwill impairment if the operational conditions of Chifeng Ruiyang do not improve or if its profitability does not meet expectations [2]. Disclosure and Compliance - The company has confirmed that there are no undisclosed significant events apart from the planned issuance of A-shares disclosed on August 14, 2024 [3].